Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AVZO-1418 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on AVZO-1418, a putative bispecific antibody-drug conjugate (ADC) targeting EGFR and ERBB3 (HER3) (Jul 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AVZO-1418 | AVZO1418|AVZO1418 | EGFR Antibody 72 HER3 (ERBB3) Antibody 28 | Limited information is currently available on AVZO-1418, a putative bispecific antibody-drug conjugate (ADC) targeting EGFR and ERBB3 (HER3) (Jul 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07038343 | Phase Ib/II | AVZO-1418 | Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) | Recruiting | USA | 0 |